What are PhRMA Foundation Value Assessment Initiative Research Awards?
The PhRMA Foundation launched its value assessment Research Awards in 2018, providing $300,000 yearly to support three leading national researchers whose work is impacting the development of new value-based care models in the United States. The researchers receive one-year grants of $100,000 to advance their work related to value-based care and cost-effectiveness in health care.
The Foundation seeks proposals to identify and address challenges in approaches used to assess the value of medicines and health care services.
Application deadline for 2022 Research Awards will be announced shortly.
Past Research Award Recipients
2021
Diana Brixner, PhD, of The University of Utah, Department of Pediatrics, Division of Clinical Pharmacology – Understanding Patient Cost Sharing Thresholds for High and Low Value Care Towards Development of a Value-Based Formulary
Surachat Ngorsuraches, PhD, of Harrison School of Pharmacy, Auburn University, Department of Health Outcomes Research and Policy Measuring the Value of Fear of Contagion in COVID-19 Care
Natalia Olchanski, PhD, of Tufts Medical Center’s Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies – Estimating the Value of Diabetes Prevention Programs Using Real-World Data
2020
David Kim, PhD of Tufts Medical Center – Developing a quality assessment tool for cost-effectiveness analysis
Lisa Prosser, PhD of the University of Michigan – Development and Validation of a Preference-Based Index for the PEDS-QL
Wendy Ungar, MSc, PhD of the Hospital for Sick Children Research Institute – Family Matters: Expanding the economic value paradigm for precision medicine diagnostics to include the costs and health consequences of family members
2019
Louis P. Garrison, Jr., PhD of the University of Washington – Implementing Augmented Cost-Effective Analysis: Challenges and Next Steps
Quang A. Le, PharmD, PhD from the Western University of Health Sciences – New Approach in Value Assessment of Health Interventions Using Doubly Randomized Preference Trial (DRPT) Design
Eleanor M. Perfetto, PhD, MS from the National Health Council – Methods Principles for Using Patient-Provided to Improve Real-World Value Assessment
2018 (inaugural year)
Josh J. Carlson, PhD, of the University of Washington – Exploring methods to improve utility adjustment in cost-effectiveness models and their impact on model outcomes
Shelby D. Reed, PhD, of the Duke Clinical Research Institute – Quantifying the Value of Hope in Cancer Care
Gillian Sanders Schmidler, PhD, of Duke-Margolis Center for Health Policy – Exploring Value-Based Care from Various Perspectives
